Colestipol is an antihyperlipidemic drug approved by the United States Food and Drug Administration (FDA) as an adjunctive therapy to lower elevated low-density lipoprotein cholesterol in patients with primary hypercholesterolemia unresponsive to dietary modifications alone. The drug can be used as monotherapy or in conjunction with a statin, niacin, or ezetimibe. Colestipol is a cholesterol-lowering drug that reduces the risk of coronary artery disease. This drug belongs to the class of bile acid sequestrants and is one of the earliest drugs used for this purpose. However, the current predominant application involves providing supplementary therapy, especially in cases where statins or alternative lipid-lowering agents prove inadequate in sufficiently reducing cholesterol levels. The drug is adjunctive to dietary modifications and exercise. In addition, colestipol is used off-label to treat cholestatic pruritus and irritable bowel syndrome. This activity emphasizes the indications, mechanism of action, adverse event profile, administration, pharmacokinetics, and monitoring strategies for colestipol. This activity provides healthcare professionals with a scientific foundation for effectively treating primary hypercholesterolemia and related conditions. In addition, this activity assists healthcare providers in decision-making regarding colestipol prescription and optimizing dosage regimens to minimize adverse reactions, thereby promoting desired patient outcomes.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/148937
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, All Practice Areas (e.g. ethics), Cardiovascular Disease, Endocrinology, Diabetes, and Metabolism, Gastroenterology, General Pediatrics, General Surgery, Hospital Medicine, Internal Medicine, Pediatric Endocrinology, Pediatric Gastroenterology